within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A02B_DrugsForPepticUlcerAndGastroOesophagealRefluxDis.A02BA04_Nizatidine;

model Nizatidine
  extends Pharmacolibrary.Drugs.ATC.A.A02BA04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Nizatidine</td></tr><tr><td>ATC code:</td><td>A02BA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Nizatidine is a histamine H2-receptor antagonist used to reduce stomach acid production, commonly prescribed for the treatment of peptic ulcers and gastroesophageal reflux disease (GERD). It is an approved drug and still clinically used.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after a single oral dose.</p><h4>References</h4><ol><li><p>Avner, DL (2000). Clinical experience with pantoprazole in gastroesophageal reflux disease. <i>Clinical therapeutics</i> 22(10) 1169â€“1150. DOI:<a href=\"https://doi.org/10.1016/s0149-2918(00)83061-1\">10.1016/s0149-2918(00)83061-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11110229/\">https://pubmed.ncbi.nlm.nih.gov/11110229</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Nizatidine;
